Global Immunogenicity Testing Service Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Immunogenicity Testing Service
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Immunogenicity Testing Service by Type
        1.3.1 Overview: Global Immunogenicity Testing Service Market Size by Type: 2017 Versus 2021 Versus 2028
        1.3.2 Global Immunogenicity Testing Service Consumption Value Market Share by Type in 2021
        1.3.3 A Single Assay
        1.3.4 Two Assays
    1.4 Global Immunogenicity Testing Service Market by Application
        1.4.1 Overview: Global Immunogenicity Testing Service Market Size by Application: 2017 Versus 2021 Versus 2028
        1.4.2 Enterprise
        1.4.3 Factory
    1.5 Global Immunogenicity Testing Service Market Size & Forecast
    1.6 Global Immunogenicity Testing Service Market Size and Forecast by Region
        1.6.1 Global Immunogenicity Testing Service Market Size by Region: 2017 VS 2021 VS 2028
        1.6.2 Global Immunogenicity Testing Service Market Size by Region, (2017-2028)
        1.6.3 North America Immunogenicity Testing Service Market Size and Prospect (2017-2028)
        1.6.4 Europe Immunogenicity Testing Service Market Size and Prospect (2017-2028)
        1.6.5 Asia-Pacific Immunogenicity Testing Service Market Size and Prospect (2017-2028)
        1.6.6 South America Immunogenicity Testing Service Market Size and Prospect (2017-2028)
        1.6.7 Middle East and Africa Immunogenicity Testing Service Market Size and Prospect (2017-2028)
2 Company Profiles
    2.1 Profacgen
        2.1.1 Profacgen Details
        2.1.2 Profacgen Major Business
        2.1.3 Profacgen Immunogenicity Testing Service Product and Solutions
        2.1.4 Profacgen Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2017-2022)
        2.1.5 Profacgen Recent Developments and Future Plans
    2.2 Charles River Laboratories
        2.2.1 Charles River Laboratories Details
        2.2.2 Charles River Laboratories Major Business
        2.2.3 Charles River Laboratories Immunogenicity Testing Service Product and Solutions
        2.2.4 Charles River Laboratories Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2017-2022)
        2.2.5 Charles River Laboratories Recent Developments and Future Plans
    2.3 Pacific BioLabs
        2.3.1 Pacific BioLabs Details
        2.3.2 Pacific BioLabs Major Business
        2.3.3 Pacific BioLabs Immunogenicity Testing Service Product and Solutions
        2.3.4 Pacific BioLabs Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2017-2022)
        2.3.5 Pacific BioLabs Recent Developments and Future Plans
    2.4 Celerion
        2.4.1 Celerion Details
        2.4.2 Celerion Major Business
        2.4.3 Celerion Immunogenicity Testing Service Product and Solutions
        2.4.4 Celerion Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2017-2022)
        2.4.5 Celerion Recent Developments and Future Plans
    2.5 Precision Medicine Group
        2.5.1 Precision Medicine Group Details
        2.5.2 Precision Medicine Group Major Business
        2.5.3 Precision Medicine Group Immunogenicity Testing Service Product and Solutions
        2.5.4 Precision Medicine Group Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2017-2022)
        2.5.5 Precision Medicine Group Recent Developments and Future Plans
    2.6 BioAgilytix
        2.6.1 BioAgilytix Details
        2.6.2 BioAgilytix Major Business
        2.6.3 BioAgilytix Immunogenicity Testing Service Product and Solutions
        2.6.4 BioAgilytix Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2017-2022)
        2.6.5 BioAgilytix Recent Developments and Future Plans
    2.7 FyoniBio
        2.7.1 FyoniBio Details
        2.7.2 FyoniBio Major Business
        2.7.3 FyoniBio Immunogenicity Testing Service Product and Solutions
        2.7.4 FyoniBio Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2017-2022)
        2.7.5 FyoniBio Recent Developments and Future Plans
    2.8 Chimera Biotec
        2.8.1 Chimera Biotec Details
        2.8.2 Chimera Biotec Major Business
        2.8.3 Chimera Biotec Immunogenicity Testing Service Product and Solutions
        2.8.4 Chimera Biotec Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2017-2022)
        2.8.5 Chimera Biotec Recent Developments and Future Plans
    2.9 Alcyomics
        2.9.1 Alcyomics Details
        2.9.2 Alcyomics Major Business
        2.9.3 Alcyomics Immunogenicity Testing Service Product and Solutions
        2.9.4 Alcyomics Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2017-2022)
        2.9.5 Alcyomics Recent Developments and Future Plans
    2.10 ProImmune 
        2.10.1 ProImmune Details
        2.10.2 ProImmune Major Business
        2.10.3 ProImmune Immunogenicity Testing Service Product and Solutions
        2.10.4 ProImmune Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2017-2022)
        2.10.5 ProImmune Recent Developments and Future Plans
    2.11 Creative Biolabs
        2.11.1 Creative Biolabs Details
        2.11.2 Creative Biolabs Major Business
        2.11.3 Creative Biolabs Immunogenicity Testing Service Product and Solutions
        2.11.4 Creative Biolabs Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2017-2022)
        2.11.5 Creative Biolabs Recent Developments and Future Plans
    2.12 SGS
        2.12.1 SGS Details
        2.12.2 SGS Major Business
        2.12.3 SGS Immunogenicity Testing Service Product and Solutions
        2.12.4 SGS Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2017-2022)
        2.12.5 SGS Recent Developments and Future Plans
    2.13 Eurofins Scientific
        2.13.1 Eurofins Scientific Details
        2.13.2 Eurofins Scientific Major Business
        2.13.3 Eurofins Scientific Immunogenicity Testing Service Product and Solutions
        2.13.4 Eurofins Scientific Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2017-2022)
        2.13.5 Eurofins Scientific Recent Developments and Future Plans
    2.14 Syrinx Bioanalytics
        2.14.1 Syrinx Bioanalytics Details
        2.14.2 Syrinx Bioanalytics Major Business
        2.14.3 Syrinx Bioanalytics Immunogenicity Testing Service Product and Solutions
        2.14.4 Syrinx Bioanalytics Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2017-2022)
        2.14.5 Syrinx Bioanalytics Recent Developments and Future Plans
    2.15 Pharmaron
        2.15.1 Pharmaron Details
        2.15.2 Pharmaron Major Business
        2.15.3 Pharmaron Immunogenicity Testing Service Product and Solutions
        2.15.4 Pharmaron Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2017-2022)
        2.15.5 Pharmaron Recent Developments and Future Plans
    2.16 NorthEast BioAnalytical Laboratories
        2.16.1 NorthEast BioAnalytical Laboratories Details
        2.16.2 NorthEast BioAnalytical Laboratories Major Business
        2.16.3 NorthEast BioAnalytical Laboratories Immunogenicity Testing Service Product and Solutions
        2.16.4 NorthEast BioAnalytical Laboratories Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2017-2022)
        2.16.5 NorthEast BioAnalytical Laboratories Recent Developments and Future Plans
    2.17 Svar Life Science
        2.17.1 Svar Life Science Details
        2.17.2 Svar Life Science Major Business
        2.17.3 Svar Life Science Immunogenicity Testing Service Product and Solutions
        2.17.4 Svar Life Science Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2017-2022)
        2.17.5 Svar Life Science Recent Developments and Future Plans
    2.18 CellCarta
        2.18.1 CellCarta Details
        2.18.2 CellCarta Major Business
        2.18.3 CellCarta Immunogenicity Testing Service Product and Solutions
        2.18.4 CellCarta Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2017-2022)
        2.18.5 CellCarta Recent Developments and Future Plans
    2.19 BioGenes
        2.19.1 BioGenes Details
        2.19.2 BioGenes Major Business
        2.19.3 BioGenes Immunogenicity Testing Service Product and Solutions
        2.19.4 BioGenes Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2017-2022)
        2.19.5 BioGenes Recent Developments and Future Plans
    2.20 EpiVax
        2.20.1 EpiVax Details
        2.20.2 EpiVax Major Business
        2.20.3 EpiVax Immunogenicity Testing Service Product and Solutions
        2.20.4 EpiVax Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2017-2022)
        2.20.5 EpiVax Recent Developments and Future Plans
    2.21 ImmunXperts
        2.21.1 ImmunXperts Details
        2.21.2 ImmunXperts Major Business
        2.21.3 ImmunXperts Immunogenicity Testing Service Product and Solutions
        2.21.4 ImmunXperts Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2017-2022)
        2.21.5 ImmunXperts Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Immunogenicity Testing Service Revenue and Share by Players (2017-2022)
    3.2 Market Share Analysis (2021)
        3.2.1 Market Share of Immunogenicity Testing Service by Company Revenue
        3.2.2 Top 3 Immunogenicity Testing Service Players Market Share in 2021
        3.2.3 Top 6 Immunogenicity Testing Service Players Market Share in 2021
    3.3 Immunogenicity Testing Service Market: Overall Company Footprint Analysis
        3.3.1 Immunogenicity Testing Service Market: Region Footprint
        3.3.2 Immunogenicity Testing Service Market: Company Product Type Footprint
        3.3.3 Immunogenicity Testing Service Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
    4.1 Global Immunogenicity Testing Service Consumption Value and Market Share by Type (2017-2022)
    4.2 Global Immunogenicity Testing Service Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Immunogenicity Testing Service Consumption Value Market Share by Application (2017-2022)
    5.2 Global Immunogenicity Testing Service Market Forecast by Application (2023-2028)
6 North America
    6.1 North America Immunogenicity Testing Service Consumption Value by Type (2017-2028)
    6.2 North America Immunogenicity Testing Service Consumption Value by Application (2017-2028)
    6.3 North America Immunogenicity Testing Service Market Size by Country
        6.3.1 North America Immunogenicity Testing Service Consumption Value by Country (2017-2028)
        6.3.2 United States Immunogenicity Testing Service Market Size and Forecast (2017-2028)
        6.3.3 Canada Immunogenicity Testing Service Market Size and Forecast (2017-2028)
        6.3.4 Mexico Immunogenicity Testing Service Market Size and Forecast (2017-2028)
7 Europe
    7.1 Europe Immunogenicity Testing Service Consumption Value by Type (2017-2028)
    7.2 Europe Immunogenicity Testing Service Consumption Value by Application (2017-2028)
    7.3 Europe Immunogenicity Testing Service Market Size by Country
        7.3.1 Europe Immunogenicity Testing Service Consumption Value by Country (2017-2028)
        7.3.2 Germany Immunogenicity Testing Service Market Size and Forecast (2017-2028)
        7.3.3 France Immunogenicity Testing Service Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Immunogenicity Testing Service Market Size and Forecast (2017-2028)
        7.3.5 Russia Immunogenicity Testing Service Market Size and Forecast (2017-2028)
        7.3.6 Italy Immunogenicity Testing Service Market Size and Forecast (2017-2028)
8 Asia-Pacific
    8.1 Asia-Pacific Immunogenicity Testing Service Consumption Value by Type (2017-2028)
    8.2 Asia-Pacific Immunogenicity Testing Service Consumption Value by Application (2017-2028)
    8.3 Asia-Pacific Immunogenicity Testing Service Market Size by Region
        8.3.1 Asia-Pacific Immunogenicity Testing Service Consumption Value by Region (2017-2028)
        8.3.2 China Immunogenicity Testing Service Market Size and Forecast (2017-2028)
        8.3.3 Japan Immunogenicity Testing Service Market Size and Forecast (2017-2028)
        8.3.4 South Korea Immunogenicity Testing Service Market Size and Forecast (2017-2028)
        8.3.5 India Immunogenicity Testing Service Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Immunogenicity Testing Service Market Size and Forecast (2017-2028)
        8.3.7 Australia Immunogenicity Testing Service Market Size and Forecast (2017-2028)
9 South America
    9.1 South America Immunogenicity Testing Service Consumption Value by Type (2017-2028)
    9.2 South America Immunogenicity Testing Service Consumption Value by Application (2017-2028)
    9.3 South America Immunogenicity Testing Service Market Size by Country
        9.3.1 South America Immunogenicity Testing Service Consumption Value by Country (2017-2028)
        9.3.2 Brazil Immunogenicity Testing Service Market Size and Forecast (2017-2028)
        9.3.3 Argentina Immunogenicity Testing Service Market Size and Forecast (2017-2028)
10 Middle East & Africa
    10.1 Middle East & Africa Immunogenicity Testing Service Consumption Value by Type (2017-2028)
    10.2 Middle East & Africa Immunogenicity Testing Service Consumption Value by Application (2017-2028)
    10.3 Middle East & Africa Immunogenicity Testing Service Market Size by Country
        10.3.1 Middle East & Africa Immunogenicity Testing Service Consumption Value by Country (2017-2028)
        10.3.2 Turkey Immunogenicity Testing Service Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Immunogenicity Testing Service Market Size and Forecast (2017-2028)
        10.3.4 UAE Immunogenicity Testing Service Market Size and Forecast (2017-2028)
11 Market Dynamics
    11.1 Immunogenicity Testing Service Market Drivers
    11.2 Immunogenicity Testing Service Market Restraints
    11.3 Immunogenicity Testing Service Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War
12 Upstream and Industry Chain
    12.1 Raw Material of Immunogenicity Testing Service and Key Suppliers
    12.2 Manufacturing Costs Percentage of Immunogenicity Testing Service
    12.3 Immunogenicity Testing Service Production Process
    12.4 Industry Value Chain Analysis
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer